Join the club for FREE to access the whole archive and other member benefits.

Billionaire Jim Mellon invests in anti-ageing research firm

11-Apr-2017

Key points from article :

Insilico Medicine applying big data analytics to extend healthy longevity.

pursuing internal drug discovery in cancer, Parkinson’s, Alzheimer’s, sarcopenia and in geroprotectors.

Investment will fund validation of the many molecules discovered using machine learning.

Company has published studies including minute changes in gene expression between young and old tissues.

Mentioned in this article:

Click on resource name for more details.

Alex Zhavoronkov

CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation

Calico

Combating aging and associated diseases. An Alphabet (Google) subsidiary.

Insilico Medicine

Biotechnology company that uses artificial intelligence to develop new drugs and for aging research

Jim Mellon

British entrepreneur, author and philanthropist with interests across a number of industries

Juvenescence: Investing in the Age of Longevity

Amazon

The book written by Jim Mellon & Al Chalabi investigates the new technologies and explains how to benefit from the life extending technologies

Life Extension

Company that sells supplements and vitamins.